AAM
CORT icon

AMI Asset Management’s Corcept Therapeutics CORT Stock Holding History

AMI Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-775,685
Closed -$11M – 82
2019
Q3 		$11M Sell
775,685
-128,435
-14% -$1.58M 0.57% 41
2019
Q2 		$10.1M Buy
904,120
+181,188
+25% +$2.02M 0.5% 58
2019
Q1 		$8.49M Sell
722,932
-31,873
-4% -$396K 0.63% 60
2018
Q4 		$10.1M Buy
754,805
+125,444
+20% +$1.66M 0.83% 43
2018
Q3 		$8.82M Sell
629,361
-53,209
-8% -$744K 0.6% 59
2018
Q2 		$10.7M Sell
682,570
-26,730
-4% -$465K 0.77% 54
2018
Q1 		$11.7M Buy
709,300
+83,918
+13% +$1.55M 0.83% 52
2017
Q4 		$11.3M Buy
625,382
+97,867
+19% +$1.77M 0.78% 56
2017
Q3 		$10.2M Buy
+527,515
New +$7.87M 0.72% 58

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AMI Asset Management's CORT Position: Q4 2019 in Review

AMI Asset Management sold out of Corcept Therapeutics (CORT) in Q4 2019, closing a stake of 775,685 shares — an estimated $11M sold.

AMI Asset Management first reported a position in CORT in Q3 2017 and held it in 9 quarters. The position peaked at $11.7M in Q1 2018. 205 funds tracked by Wall St. Rank hold CORT as of Q4 2019.

  • AMI Asset Management reported no remaining Corcept Therapeutics position as of Q4 2019 after selling out during the quarter.
  • AMI Asset Management sold 775,685 Corcept Therapeutics shares in Q4 2019, an estimated $11M.
  • AMI Asset Management first reported a position in Corcept Therapeutics in Q3 2017 and held it in 9 quarters.
  • AMI Asset Management's Corcept Therapeutics position peaked at $11.7M in Q1 2018.
  • 205 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2019.

Based on AMI Asset Management's 13F filing for Q4 2019, filed 23 Jan 2020.